Compugen Ltd. (CGEN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.8600 |
| Open | 1.8800 |
| Bid | 2.3200 x 100 |
| Ask | 2.3800 x 100 |
| Day's Range | 1.8800 - 2.4300 |
| 52 Week Range | 0.5300 - 3.0300 |
| Volume | |
| Avg. Volume | 509,824 |
| Market Cap | 209.501M |
| Beta (5Y Monthly) | 2.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
Simply Wall St.Earnings Release: Here's Why Analysts Cut Their Compugen Ltd. (NASDAQ:CGEN) Price Target To US$5.00
Compugen Ltd. ( NASDAQ:CGEN ) just released its first-quarter report and things are looking bullish. Revenue crushed...
ZacksCompugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
Compugen (CGEN) delivered earnings and revenue surprises of 20% and 8.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
PR NewswireCompugen Reports First Quarter 2024 Results
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced financial results for the first quarter ended March 31, 2024 and provided a corporate update.
© 2024 Yahoo. All rights reserved.